Literature DB >> 18804305

Incidence of type 1 and type 2 diabetes in adults and children in Kronoberg, Sweden.

M Thunander1, C Petersson, K Jonzon, J Fornander, B Ossiansson, C Torn, S Edvardsson, M Landin-Olsson.   

Abstract

All newly diagnosed diabetes in Kronoberg during 3 years was registered, with blood samples from 1630/1666 (97.8%) adults. Those positive for GADab and/or ICA and/or C-peptide<0.25nmol/L (0.7%) were classified as type 1 diabetes, the remaining as type 2. Incidence of type 1 in 0-19-year-olds was 37.8(36.1-39.6, 95%CI) and in 20-100 year-olds 27.1(25.6-27.4) per 100 000 and year, it was bimodal with equal peaks in 0-9 year-olds and in 50-80-year-olds. Adults had type 2 incidence 378 (375-380), children 3.1 (2.6-3.6). Among adults 6.9% had type 1 and 93.1% type 2. Among antibodypositive adults (n=101), GADab were present in 90%, ICA in 71%, both GADab and ICA in 61%. Ophthalmology contact as second source was confirmed for 98%. There were no gender differences in type 1 in any age group, small ones in pediatric subgroups. In type 2 men predominated in ages above 40 years. Incidences of type 1 diabetes in both children and adults were very high and as high above age 50 years as in children. Incidence of type 2 was the highest reported from Sweden, to which new diagnostic criteria, a high degree of case-finding, and many elders, may have contributed, but results may also reflect a true increase in incidence of both types of diabetes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18804305     DOI: 10.1016/j.diabres.2008.07.022

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  60 in total

1.  Latent autoimmune diabetes in adults (LADA) is dead: long live autoimmune diabetes!

Authors:  O Rolandsson; J P Palmer
Journal:  Diabetologia       Date:  2010-03-25       Impact factor: 10.122

Review 2.  Epidemiology of type 1 diabetes.

Authors:  David M Maahs; Nancy A West; Jean M Lawrence; Elizabeth J Mayer-Davis
Journal:  Endocrinol Metab Clin North Am       Date:  2010-09       Impact factor: 4.741

3.  How to diagnose and classify diabetes in primary health care: lessons learned from the Diabetes Register in Northern Sweden (DiabNorth).

Authors:  Olov Rolandsson; Margareta Norberg; Lennarth Nyström; Stefan Söderberg; Maria Svensson; Bernt Lindahl; Lars Weinehall
Journal:  Scand J Prim Health Care       Date:  2012-06       Impact factor: 2.581

4.  Management of Type 1 Diabetes in Older Adults.

Authors:  Ruban Dhaliwal; Ruth S Weinstock
Journal:  Diabetes Spectr       Date:  2014-02

Review 5.  Blood-based signatures in type 1 diabetes.

Authors:  Susanne M Cabrera; Yi-Guang Chen; William A Hagopian; Martin J Hessner
Journal:  Diabetologia       Date:  2015-12-23       Impact factor: 10.122

6.  Race, vitamin D-binding protein gene polymorphisms, 25-hydroxyvitamin D, and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Jared P Reis; Erin D Michos; Elizabeth Selvin; James S Pankow; Pamela L Lutsey
Journal:  Am J Clin Nutr       Date:  2015-04-29       Impact factor: 7.045

Review 7.  Emerging Approaches in Surveillance of Type 1 Diabetes.

Authors:  Sharon Saydah; Giuseppina Imperatore
Journal:  Curr Diab Rep       Date:  2018-07-11       Impact factor: 4.810

Review 8.  The pathogenesis and natural history of type 1 diabetes.

Authors:  Mark A Atkinson
Journal:  Cold Spring Harb Perspect Med       Date:  2012-11-01       Impact factor: 6.915

9.  Worse glycaemic control in LADA patients than in those with type 2 diabetes, despite a longer time on insulin therapy.

Authors:  C D Andersen; L Bennet; L Nyström; U Lindblad; E Lindholm; L Groop; O Rolandsson
Journal:  Diabetologia       Date:  2012-10-25       Impact factor: 10.122

Review 10.  Global trends in the incidence and prevalence of type 2 diabetes in children and adolescents: a systematic review and evaluation of methodological approaches.

Authors:  S Fazeli Farsani; M P van der Aa; M M J van der Vorst; C A J Knibbe; A de Boer
Journal:  Diabetologia       Date:  2013-05-16       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.